Juergen Peter Bachl

Title: Juergen Peter Bachl: Innovator in Bispecific Antigen Binding Molecules

Introduction

Juergen Peter Bachl is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of biochemistry, particularly in the development of bispecific antigen binding molecules. His innovative work has the potential to impact therapeutic approaches in various medical applications.

Latest Patents

Juergen Peter Bachl holds a patent for bispecific antigen binding molecules targeting OX40 and Fibroblast Activation Protein (FAP). This invention relates to novel bispecific antigen binding molecules that comprise at least two antigen binding domains capable of specific binding to OX40 and a particular antigen binding domain capable of specific binding to FAP. The patent also covers methods of producing these molecules and methods of using them.

Career Highlights

Juergen is currently employed at Hoffmann-La Roche Inc., a leading global healthcare company. His work at this esteemed organization allows him to collaborate with other experts in the field and contribute to groundbreaking research and development.

Collaborations

Throughout his career, Juergen has worked alongside talented colleagues, including Maria Amann and Alexander Bujotzek. These collaborations have fostered an environment of innovation and creativity, leading to advancements in their respective fields.

Conclusion

Juergen Peter Bachl's contributions to the development of bispecific antigen binding molecules highlight his role as a key innovator in biochemistry. His work not only advances scientific knowledge but also holds promise for future therapeutic applications.